US equities
|
MU
$904.90
▲+0.00%
SNDK
$1,371.12
▲+0.00%
NVDA
$217.09
▲+0.00%
SKHY
$142.87
▲+0.00%
SPCX
$147.96
▲+0.00%
AAPL
$342.94
▲+0.00%
TSLA
$368.06
▲+0.00%
CRWV
$61.12
▲+0.00%
MU
$904.90
▲+0.00%
SNDK
$1,371.12
▲+0.00%
NVDA
$217.09
▲+0.00%
SKHY
$142.87
▲+0.00%
SPCX
$147.96
▲+0.00%
AAPL
$342.94
▲+0.00%
TSLA
$368.06
▲+0.00%
CRWV
$61.12
▲+0.00%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about Aitan Zacharin
Recent news which mentions Aitan Zacharin
Cannabinoids & Autism Spectrum Disorder: This Baltimore Company Is On Track To Start Phase 2 Clinical Trial For New Treatment
October 07, 2022
Tickers
CBD
GCAN
Tags
cannabinoids
Cannabis
News
From
Benzinga